Jeffrey Daniel Bernstein - May 8, 2023 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Director
Signature
/s/ Jamison Yardley, Attorney-in-fact
Stock symbol
PRVA
Transactions as of
May 8, 2023
Transactions value $
-$536,472,909
Form type
4
Date filed
5/10/2023, 04:37 PM
Previous filing
Nov 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock Sale -$536M -24.8M -99.56% $21.62 110K May 8, 2023 See footnotes F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an underwriting agreement, dated May 4, 2023 (the "Underwriting Agreement"), Broad Street Principal Investments, L.L.C., MBD 2013 Holdings L.P. and Bridge Street 2013 Holdings L.P. offered and sold an aggregate 24,819,473 shares of Common Stock as set forth in the final prospectus filed by the Issuer on May 5, 2023, which offering was consummated on May 8, 2023 (the "Offering"). The amount above represents the $22.00 public offering price per share of Common Stock in the Offering less the underwriting discount of $0.385 per share of Common Stock.
F2 The Reporting Person is a managing director of Goldman Sachs & Co. LLC ("Goldman Sachs"). Goldman Sachs is a subsidiary of The Goldman Sachs Group, Inc. ("GS Group"). The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein, if any.